Sirtuins in Central Nervous System Tumors-Molecular Mechanisms and Therapeutic Targeting

Agnieszka Nowacka1, Martyna Śniegocka2, Maciej Śniegocki1

  • 1Department of Neurosurgery, Collegium Medicum in Bydgoszcz, Nicolas Copernicus University in Toruń, ul. Curie Skłodowskiej 9, 85-094 Bydgoszcz, Poland.

Cells
|July 25, 2025
PubMed

Insights

Sirtuins (SIRTs) impact glioma by promoting or suppressing tumors. Modulators targeting these enzymes show promise for novel glioma therapies and patient stratification.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Sirtuins (SIRTs) are NAD+-dependent enzymes involved in critical cellular processes.
  • Their roles in epigenetic regulation, metabolism, DNA repair, and stress response are relevant to glioma biology.

Purpose of the Study:

  • To systematically review the molecular mechanisms and context-specific functions of SIRT1-SIRT7 in central nervous system tumors, focusing on gliomas.
  • To explore the therapeutic potential of sirtuin modulators in glioma treatment.

Main Methods:

  • Systematic review of literature on sirtuins in central nervous system tumors.
  • Analysis of preclinical studies on sirtuin modulators and their effects on glioma cells.

Main Results:

  • SIRT1, SIRT3, SIRT5, and SIRT7 are frequently overexpressed, promoting glioma progression.
  • SIRT2, SIRT4, and SIRT6 generally act as tumor suppressors.
  • Sirtuin modulators impact tumor growth, chemoresistance, and key signaling pathways (e.g., JAK2/STAT3, NF-κB).

Conclusions:

  • Sirtuins represent promising therapeutic targets for glioma.
  • Further clinical evaluation of sirtuin modulators is warranted for combined strategies and patient stratification.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.0K